Vaginitis and the problems of their treatment
Authors/Creators
Description
A review of the literature on the causes of vaginitis, vaginal microflora in women with various pathological conditions - bacterial vaginosis, vaginal candidiasis and nonspecific vaginitis, treatment with systemic and local drugs and the prospects for vaginitis therapy with local agents based on vegetable oil - is presented. Vaginitis is a disease that in itself does not pose a direct threat to women's health, but in the lower parts of the genital tract accumulate and constantly stored in extremely high concentrations of opportunistic pathogens, which are the main causative agents of purulent-inflammatory diseases of the pelvic organs The state of the microbiocenosis of the vaginal mucosa is of great importance for women's reproductive health. Changes in the qualitative and quantitative composition of microorganisms in this locus, as well as their relationship with the cells of the macroorganism can lead to the development of vaginal dysbiosis or vulvovaginitis. The nature of disorders of the vaginal microflora in BV is due to the range of microorganisms involved in the development of this disease, which cause a complex of qualitative and quantitative changes in the vaginal microflora. This is due to a decrease in the number or absence of H2O2-producing lactobacilli, an increase in the number of G. vaginalis, gram-negative anaerobic bacteria - Mobiluncus spp., Prevotella spp., Bacteroides spp., Fusobacterium spp., Peptostreptococcus spp., M. hominis U. urealyticum; a small amount of Candida and an increase in the total number of microorganisms in the vaginal microflora. Recently, an important role in the treatment of vaginitis belongs to drugs based on plant raw materials, the advantage of which is a complex action, low toxicity, long-term use without the risk of side effects. According to the literature, black cumin oil, which contains a wide range of biologically active substances, can be used as the active substance of a new drug of local action in the form of suppositories for the treatment of vaginitis. At the same time, the development and further implementation of a drug based on black cumin oil in gynecological practice will increase the effectiveness of treatment of infectious diseases of the female genital organs and avoid many of the above negative effects of traditional therapy
Files
dovgaFIN.pdf
Additional details
References
- 1. Gorshkova O. V., Chizhova G. V., Molodtsova L. Yu., Morozova O. N. Ways to optimize the treatment of vaginal infections on an outpatient basis. Medical advice. 2018. No. 13. P. 130–134.
- 2. Kira E. F., Muslimova S. Z. Nonspecific vaginitis and its impact on women's reproductive health. Probl. reprod. 2008. No. 5. P. 8–14.
- 3. Ventolini G. Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis. Womens Health (Lond.), 2016. Vol.12, № 3. Р. 283–291.
- 4. Treatment of bacterial vaginosis and mixed infections in women with background processes in the epithelium of the cervix / O. M. Boris et al. Women's health. 2011. No. 1 (57). Р. 82–90.
- 5. Mamedalieva N. M. Modern approaches to the treatment of bacterial vaginosis. Medicine (Almaty). 2016. No. 6 (168). Р. 57–60.
- 6. Shireva Yu. V., Sandakova E. A., Karpunina T. I. Nonspecific aerobic vaginitis – "new" or "old" disease? (review). Medical almanac. 2010. No. 4 (13). Р.164–168.
- 7. Kosey N. V. Modern principles of treatment of inflammatory diseases of female genital organs. Reproductive endocrinology. 2013. No. 1 (9). Р. 78–85.
- 8. Tkachenko L. V., Uglova N. D., Sviridova N. I., Skladanovskaya T. V. Modern approach to the treatment of vulvovaginal infections. Obstetrics and gynecology: news, opinions, training. 2018. Vol. 6, No. 4. Р. 52–58.
- 9. Nikitina I. M. Peculiarities of biocenosis and functional activity of the vaginal epithelium in case of malignant nonspecific vaginitis. Current nutrition of pediatrics, obstetrics and gynecology. 2017. No. 2. Р. 61–66.
- Lysakova N. V. Nonspecific vaginitis: modern principles of treatment. Bulletin of surgery of Kazakhstan. 2012. No. 4. Р. 67–69.
- 11. Sokolova T. M., Marinkin I. O., Kuleshov V. M., Makarov K. Yu. Experience in the use of a new combination drug for the treatment of urogenital infections. Obstetrics and gynecology: news, opinions, training. 2019. Vol. 7, No. 2. Р. 69–72.
- 12. Malanchuk L. M., Malanchuk S. L., Nessio T. A. Vaginal microbiota as a way to restore balance in dysbiosis. Women's health. 2016. No. 2 (108). Р. 107–111.
- Pirogova V.I., Malachinska M.Y., Shurpyak S.O., Shchuruk N.V. Microecology of the pharynx - what an obstetrician-gynecologist needs to know (clinical lecture). Women's health. 2015. No. 7 (103). Р. 8–13.
- 14. Rybina E. V. Modern methods for assessing the microbiocenosis of the vagina. Journal of Obstetrics and Women's Diseases. 2015. Vol. LXIV, Issue. 1. P. 53–66.
- Voida Yu. V., Solonina NL Human microecology and the role of probiotic preparations in the treatment of pyoinflammatory diseases. Annals of Mechnikov Institute. 2012. No. 2. Р. 27–37.
- Selikhova M.S., Smolyaninov A.A. New possibilities in the treatment of vaginal infections. Obstetrics and gynecology: news, opinions, training. 2019. Vol. 7, No. 1. Р. 75–78.
- Chernyal O. L. Successful approach to correction of pathogenic microflora in bacterial vaginosis in patients with candidal colpitis. Women's health. 2015. No. 7 (103). Р. 136–138.
- Peculiarities of the transition and complex treatment of mixed infections of the uterine tract and cervix / V. O. Benyuk et al. Healthy Ukraine. 2013 No. 22 (323). Р. 47–48.
- Potapov V. A. Local therapy is a modern trend in the treatment of vaginal infections. Reproductive endocrinology. 2016. No. 5 (31). Р. 68–72.
- Malova I. O., Afanasyeva I. G., Gusevskaya K. A. Acute vaginitis of mixed etiology: a modern approach to treatment. Obstetrics and gynecology: news, opinions, training. 2019. Vol. 7, No. 4. Р. 79–86.
- Bardova K. O. Possible ways to correct damage in case of nonspecific vaginitis. Clinical Immunology. Allergology. Infectology. 2016. No. 7 (96). Р. 23–26.
- Nosenko E. N., Kaminsky A. V., Seilova A. I. Gritsenko A. S. Therapy of vaginal dysbiosis with a combination drug Limenda with high doses of intravaginal metronidazole and miconazole in women with infertility who applied for cycles of assisted reproductive technologies. Reproductive health. Eastern Europe. 2018. Vol. 8, No. 1. Р. 437–54.
- 23. Anahita Bhesania, Hodiwala Anuradha Koli. Bacterial Vaginosis. Int.J.Curr.Microbiol.App.Sci. 2015. Vol. 4, No. 6. Р. 530–538.
- Ananyeva M. M. Etiological and pathogenetic aspects of nonspecific bacterial vaginosis. Zaporozhye Medical Journal. 2018. Vol. 20, No. 3 (108). Р. 432–436.
- 25. Podolsky VV, Lisyana TO, Ponomareva IG The state of microbiocenosis of urogenital organs in women with reproductive health disorders and changes in autonomic homeostasis. Women's health. 2015. № 2 (98). P. 142–145.
- Lisovskaya E. V., Khilkevich E. G. Current trends in the treatment of bacterial vaginosis. Medical advice. 2018. No. 7. P. 106–111.
- Savicheva A. M., Tapilskaya N. I., Shipitsyna E. V., Vorobieva N. E. Bacterial vaginosis and aerobic vaginitis as the main imbalances of the vaginal microflora. Features of diagnosis and therapy. Obstetrics and gynecology. 2017. No. 5. Р. 24–31.
- Starishko OM Features of the composition of the microflora of the urogenital tract of women. Bulletin of problems of biology and medicine. 2017. Issue. 1 (135). P. 59–63.
- Vdovichenko Yu. P., Gopchuk OM Bacterial vaginosis - monotherapy with combined drugs. Women's health. 2016. №1 (107). P. 132–136.
- 30. Vaginal microbiome of reproductive-age women / J. Ravel et al. Proc. Natl. Acad. Sci. U S A. 2011. Vol. 108, No. 1. Р. 4680–4687. doi: 10.1073 / pnas.1002611107.
- Benyuk VO, Shcherba OA, Lastovetskaya LD Functional state of the vaginal mucosa in bacterial vaginosis and its correction. Women's health. 2017. No. 9 (125). P. 77–80.
- Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis / E. Gillet et al. PLoS One. 2012. Vol. 7, No. 10. Р. 45201.
- 33. Bebneva T.N., Dobretsova T.A. Mixed vaginal infections: a new ideology. Nonspecific vaginal infections in the practice of an obstetrician-gynecologist: a newsletter / ed.V. E. Radzinsky, A. M. Savicheva. M., 2016. 24 p.
- Mixed vaginitis – more than coinfection and with therapeutic implications / J.D. Sobel et al. Curr. Infect. Dis. Rep. 2013. Vol. 15, No. 2. P. 104–108.
- Sobel J.D., Reichman O., Misra D., Yoo W. Prognosis and treatment of desquamative infl ammatory vaginitis. Obstet. Gynecol. 2011. Vol. 117, No. 4. P. 850–855.
- Golyanovsky OV, Mehedko VV, Budchenko MA Modern approaches to the treatment of bacterial vaginosis and mixed nonspecific vaginitis. Women's health. 2017. № 8 (124). P. 89–95.
- 37. Microecological combinations of vaginal and intestinal biotopes in women with inflammatory diseases of the lower floor of the genital tract and adolescent girls with ovarian dysfunction / S. M. Popkova et al. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2013. Vol. 33, No. 4. Р. 77–84.
- 38. Swidsinski A., Verstraelen H., Loening-Baucke V. Presence of a polymicrobial endometrial biofi lm in patients with bacterial vaginosis. PloS One. 2013. Vol. 8, No. 1. P. 53–59.
- Robertson S. R., McLean R. J. C. Benefi cial biofi lms. AIMS Bioengin. 2015. Vol. 2, No. 4. P. 437–448.
- Sobel J. D., Reichman O., Misra D., Yoo W. Prognosis and treatment of desquamative infl ammatory vaginitis. Obstet. Gynecol. 2011. Vol. 117, No. 4. P. 850–855.
- 41. Infection through structured polymicrobial Gardnerella biofi lms (StPM-GB) / A. Swidsinski et al. Histol. Histopathol. 2014. Vol. 29, No. 5. P. 567–587.
- 42. Barinov S.V. Okhlopkov V.A., Babaeva T.S., Sinelnikova L.B. Conditionally pathogenic microflora in patients with bacterial. Mother and child in Kuzbassе. 2019. No 1 (76). P. 42–48.
- Vaginal biocenosis and genital infections: features of local treatment / Mayorov M. V. at all Medical aspects of women's health. 2018. No 7–8 (120–121). P.25–32.
- Olina A. A., Meteleva T. A. Modern possibilities of therapy of patients with nonspecific infectious diseases of the vagina. Russian Bulletin of an obstetrician-gynecologist. 2016. No 6. P. 89–94.
- Gamaletsou M. N., Drogari-Apiranthitou M., Denning D. W., Sipsas N. V. An estimate of the burden of serious fungal diseases in Greece. Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35, № 7. P. 1115–1120.
- 46. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina / L. Theill et al. Rev. Argent. Microbiol. 2016. Vol. 48, № 1. P. 43–49.
- Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China / F.J. Wang et al. Chin. Med. J. 2016. Vol. 129, N. 10. P. 1161–1165.
- Microbiological substantiation of the formation and development of vulvovaginal candidiasis / N. D. Yakovichuk et al. Zaporozhye Medical Journal. 2017. Vol 19, N 4(103). .P. 467–471.
- Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis / G. Fornari et al. Braz. J. Microbiol. 2016. Vol. 47, № 2. P. 373–380.
- Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors / B. Gonçalves et al. Crit. Rev. Microbiol. 2016. Vol. 42, № 6. P. 905–927.
- Treatment of vulvovaginitis and vaginosis: clinical and laboratory effectiveness / V. N. Prilepskaya et al. Gynecology. 2013.Vol. 15 (4). P. 4–9.
- Podolsky V.V., Podolsky Vl. C. Treatment of inflammatory diseases of the genital organs of fungal etiology in women of childbearing age on an outpatient basis. Women's health. 2012. N. 4 (70). P. 80–82.
- Kaminsky V. V., Boris O. M., Sumenko V. V., Gak I. O. Treatment of nonspecific vaginitis in the II-III semester of pregnancy. Women's health. 2014. N. 7 (93). P. 87–94.
- Actual approaches to the treatment of vulvovaginitis, taking into account the antibiotic resistance of infectious agents / G. M. Bondarenko et al. Scientific Journal «ScienceRise: Medical Science». 2016.N. 9 (5). P. 19–25.
- Dicke G. B. Pathological vaginal discharge: diagnosis and treatment. Doctor ru. Ginecology Endocrinology. 2018. N. 6 (150). P. 26–29.
- 56. Kuznetsova I. V., Shikh E. V. Aerobic vaginitis: terminological news and choice of empiric therapy. Women's health. 2018. N. 5 (131). P. 23–25.
- Rogozhina I. E., Neyfeld I. V., Stolyarova U. V., Skupova I. N. Optimization of treatment for women with recurrent nonspecific vaginitis and cervicitis. Infectious Diseases: News, Opinion, Education. 2017. N.1. P.70–75.
- 58. Vdovichenko Yu. P., Gopchuk G. N. Bacterial vaginosis and nonspecific vaginitis - differential diagnosis and choice of local therapy. Women's health. 2013. N. 5 (81). P. 100–104.
- Tyutyunnik V. L., Mikhailova O. I., Karapetyan T. E., Mejidova M. K. Modern concepts and basic principles of treatment of nonspecific vaginitis. Women's health. 2012. N.4 (70).P. 97–100.
- Benyuk V. O., Shcherba O. A. The microecosystem of penis in women of reproductive age and methods of correction. Women's health 2017. N. 8 (124). P. 44–50.
- Klimnyuk S. I., Mikhailishin G. I., Malanchuk L. M. Microbiological features of bacterial vaginosis in women of different age categories and ways of microbiological correction. Health benefits of clinical and experimental medicine. 2019. N. 3. P. 21–31.
- 62. Khamaganova IV Nonspecific vulvovaginitis. Medical advice.2011. N. 3–4. P. 63–68.
- 63. Limanska A. Yu., Voloshina T. V., Baider A. K., Davidova Yu., Revision of the Riving of the Pitch and Intestinal Biotope in the Preconception Period After Antibiotic Therapy. Perinatology and Pediatrics. 2017. N 1 (69). P. 33–38.
- Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates / L. Johnson et. al. The American Journal of Medicine. 2008. Vol. 121, Issue 10. Р. 876–884. doi: 10.1016/j.amjmed.2008.04.039
- 65. Kahlmeter, G. An International Survey of the Antimicrobial Susceptibility of pathogens from Uncomplicated Urinary Tract Infections: the ECO-SENS. Project. Journal of Antimicrobial Chemotherapy. 2003. Vol. 51, Issue 1. P. 69–76. doi: 10.1093/jac/dkg028
- Pustotina OA Vaginitis caused by opportunistic microflora: analysis of international and domestic protocols. Gynecology. 2015. Vol.16, N. 5. С. 27–30.
- 67. Hamster N. V. Vaginitis: possibilities and advantages of combined local therapy. Pathology of pregnancy.2019. N. 4–5 (125–126), P. 46–54.
- 68. Gorbunova O. V. Bacterial vaginosis: modern approach to healing. News of medicine and pharmacy "Reproductology. Obstetrics. Gynecology. Urology". 2018. Р. 671.
- 69. Franasiak J. M., Scott R. T. Jr. Reproductive tract microbiome in assisted reproductive technologies. Fertil. Steril. 2015. Vol. 104, № 6, Р. 4364–71. doi: 10.1016 / j.fertnstert.2015.10.012.
- Kuzmenko A. N. Features of the biota of the urogenital tract of women of reproductive age with nonspecific vulvovaginitis. Dermatology and venereology. 2015. N.3 (69). P. 36–43.
- Semkina OA Ointments, gels, liniments and creams containing herbal remedies (review). Chemical-farm. Journal 2005. Vol.39, N. 7. P. 30–36.
- 72. Modern phytotherapy: textbook. way. / SV Garna and others. Kharkiv: Madrid Printing House, 2016. - 580 p.
- Galchynska OK, Sorokina NG, Galka VI Antimicrobial and antifungal activity of essential oils. Scientific Bulletin of the National University of Life and Environmental Sciences of Ukraine. Series: Veterinary medicine, quality and safety of livestock products. 2016. Vol. 237. P.184-191.
- 74. Mikheev AO Prospects for the use of vegetable oils as antifungal agents. Zaporozhye medical journal. 2017. ТVol. 19, N. 2(101). P. 221-226.
- Chistyakov AG, Voronina IS The use of the drug Gynecophyte in the complex treatment of inflammatory diseases of the female reproductive system: an information manual for physicians. Kharkiv, 2008. 24 pp.
- 76. Botoeva EA Phytotherapy of inflammatory diseases of female genital organs. Bulletin VSNC SO RAMS. 2011. N. 1 (77), part 2. P. 31–34.
- Safiullin A.A. Thymoquinone - use in dentistry. International Journal of Applied and Basic Research.2016. N. 129. P. 1660–1662.
- Arici By Muhammet, Osman Sagdic, Umit Gecgel. Antibacterial effect of Turkish black cumin (Nigella sativa L.) oils. Grasas y Aceites. 2005. Vol. 56, Fasc. 4. Р. 259–262
- In vitro antioxidant and antibacterial activities of essentials oils obtained from Egyptian aromatic plants / M. Viuda-Martos et аl. .Food Control. 2011. Vol. 22, № 11. Р. 1715–1722
- Antibacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus / A. Hannan et al. Journal of Ayub Medical College, Abbottabad. 2008. Vol. 20, № 3. Р. 72–74.
- Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation / K. Chaieb et al. BMC Complementary and Alternative Medicine. 2011. Vol. 13, № 11. Р. 29–34.
- 82. Effect of Hibiscus sabdariffa extract and Nigella sativa oil on the growth and aflatoxin B1 production of Aspergillus flavus and Aspergillus parasiticus strains / S.A.F. El-Nagerabi et al. Food Control. 2012. Vol. 25. Is. 1. P. 59–63.
- Rud N. K., Sampiev A. M., Davitavyan N. A. The main results of phytochemical and pharmacological studies of Nigella sativa. Scientific statements of BelSU. 2013. N. 25 (168), rel. 24. P. 207–212.